Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn’s Disease-Reference-Cited by-同舟云学术

Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn’s Disease

Published:2020-07-17 Issue:8 Volume:66 Page:2700-2711
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Rhodes Jonathan M.^ORCID,Subramanian Sreedhar,Flanagan Paul K.,Horgan Graham W.,Martin Kate,Mansfield John,Parkes Miles,Hart Ailsa,Dallal Helen,Iqbal Tariq,Butterworth Jeffrey,Culshaw Kate,Probert Christopher

Funder

Crohn's and Colitis UK

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-020-06477-y.pdf

Reference36 articles.

1. Palmela C, Chevarin C, Xu Z, et al. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut. 2018;67:574–587.

2. Ryan P, Kelly RG, Lee G, et al. Bacterial DNA within granulomas of patients with Crohn’s disease—detection by laser capture microdissection and PCR. Am J Gastroenterol. 2004;99:1539–1543.

3. O’Brien CL, Pavli P, Gordon DM, et al. Detection of bacterial DNA in lymph nodes of Crohn’s disease patients using high throughput sequencing. Gut. 2014;63:1596–1606.

4. Gutiérrez A, Zapater P, Juanola O, et al. Gut bacterial DNA translocation is an independent risk factor of flare at short term in patients with Crohn’s disease. Am J Gastroenterol. 2016;111:529–540.

5. Keita ÅV, Alkaissi LY, Holm EB, et al. Enhanced E. coli LF82 translocation through follicle-associated epithelium in Crohn’s disease is dependent on long polar fimbriae and CEACAM6-expression, and increases paracellular permeability. J Crohns Colitis. 2020;14:216–229.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination treatment of inflammatory bowel disease: Present status and future perspectives;World Journal of Gastroenterology;2024-04-21

2. Specific Antibiotics Increase the Risk of Flare-Ups in Patients with Inflammatory Bowel Disease: Results from a Danish Nationwide Population-Based Nested Case-Control Study;Journal of Crohn's and Colitis;2024-02-17

3. Antibiotic Therapy for Active Crohn’s Disease Targeting Pathogens: An Overview and Update;Antibiotics;2024-02-03

4. Antibiotics for inflammatory bowel disease: Current status;Indian Journal of Gastroenterology;2024-02

5. Pathogens in Crohn's Disease: The Role of Adherent Invasive Escherichia coli;Critical Reviews in Eukaryotic Gene Expression;2024